We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+24.38%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.87B
AUM Growth
+$571M
Cap. Flow
-$98.3M
Cap. Flow %
-2.54%
Top 10 Hldgs %
18.79%
Holding
1,345
New
153
Increased
459
Reduced
571
Closed
93

Sector Composition

Rank Sector Weight
1 Technology 18.06%
2 Healthcare 12.66%
3 Financials 10.15%
4 Consumer Discretionary 9.43%
5 Communication Services 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLDT
1226
Chatham Lodging
CLDT
$580M
$66K ﹤0.01%
10,800
-1,266
-10% -$8.48K
TXMD icon
1227
TherapeuticsMD
TXMD
$24M
$61K ﹤0.01%
979
+122
+14% +$7.1K
OPK icon
1228
Opko Health
OPK
$1.04B
$59K ﹤0.01%
17,400
-300
-2% -$672
WATT icon
1229
Energous
WATT
$102M
$59K ﹤0.01%
35
FPL
1230
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$56K ﹤0.01%
13,043
-3,359
-20% -$15.1K
PTE
1231
DELISTED
PolarityTE, Inc. Common Stock
PTE
$54K ﹤0.01%
1,731
-578
-25% -$15.4K
CMCM
1232
Cheetah Mobile
CMCM
$98.1M
$53K ﹤0.01%
6,204
HIMX
1233
Himax Technologies
HIMX
$2.57B
$51K ﹤0.01%
12,240
WTER
1234
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$49K ﹤0.01%
2,293
+666
+41% +$10.9K
NGL icon
1235
NGL Energy Partners
NGL
$2.14B
$47K ﹤0.01%
+11,969
New +$56K
CTR
1236
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
$47K ﹤0.01%
3,483
-349
-9% -$4.56K
PDLI
1237
DELISTED
PDL BioPharma, Inc.
PDLI
$44K ﹤0.01%
15,188
NGD
1238
DELISTED
New Gold Inc
NGD
$40K ﹤0.01%
29,446
+1,300
+5% +$1.3K
SONM icon
1239
DNA X Inc
SONM
$5.24M
$35K ﹤0.01%
24
UMC icon
1240
United Microelectronic
UMC
$47.1B
$32K ﹤0.01%
+12,000
New +$30.2K
ATHX
1241
DELISTED
Athersys, Inc. Common Stock
ATHX
$28K ﹤0.01%
400
WLL
1242
DELISTED
Whiting Petroleum Corporation
WLL
$15K ﹤0.01%
175
-62
-26% -$4.83K
ROYT
1243
DELISTED
PACIFIC COAST OIL TRUST
ROYT
$14K ﹤0.01%
40,295
WRN
1244
Western Copper and Gold
WRN
$555M
$9K ﹤0.01%
+10,000
New +$7.06K
DMK
1245
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$9K ﹤0.01%
229
AMPE
1246
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$6K ﹤0.01%
34
ATNM icon
1247
Actinium Pharmaceuticals
ATNM
$24.2M
$5K ﹤0.01%
467
SENS icon
1248
Senseonics Holdings Inc
SENS
$394M
$4K ﹤0.01%
+500
New +$5.17K
TMUSR
1249
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
$4K ﹤0.01%
+23,190
New +$6.51K
GSAT icon
1250
Globalstar
GSAT
$10.9B
$3K ﹤0.01%
667
-13
-2% -$62

Similar funds

Oppenheimer & Co's Q2 2020 Portfolio in Review

As of Q2 2020, Oppenheimer & Co held 1,345 positions worth $3.87B, up 17% from $3.29B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oppenheimer & Co's Q2 2020 filing shows 153 new, 459 increased, 571 reduced and 93 closed positions. Its largest new stake was Chegg: 80,419 shares worth $5.41M. The largest sale was Invesco QQQ Trust, an estimated $21.5M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q2 2020 buy was Chegg: 80,419 shares worth $5.41M.
  • Oppenheimer & Co added most to ProShares Short S&P500 in Q2 2020, an estimated $10.6M increase.
  • Oppenheimer & Co's biggest Q2 2020 reduction was Invesco QQQ Trust, cutting an estimated $21.5M.
  • Oppenheimer & Co fully exited State Street SPDR Portfolio S&P 500 High Dividend ETF in Q2 2020, selling an estimated $6.47M.
  • Oppenheimer & Co's ten largest holdings make up 19% of its $3.87B portfolio in Q2 2020.
  • Oppenheimer & Co opened 153 new positions and closed 93 in Q2 2020.
  • Oppenheimer & Co's portfolio value rose 17% quarter-over-quarter to $3.87B.

Based on Oppenheimer & Co's 13F filing for Q2 2020, filed 11 Aug 2020.